Safety, efficacy and feasibility of preventive treatment for drug-resistant tuberculosis with moxifloxacin or bedaquiline

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The Zero TB project in the city of Vladimir, under which operational research was conducted, was funded through a grant from the Eli Lilly and Company Foundation to Brigham and Women's Hospital (USA) (S.K. was the Boston-based principal investigator). Data collection according to standards for the study and data analysis was supported by Partners in Health, Boston, USA. The preparation of the first draft of the manuscript was initiated during the SORT IT course funded by LHL international, Norway (A.V.S. attended this course in 2021).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB Committee of Novosibirsk Tuberculosis Research Institute of the Ministry of Health of the Russian Federation gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes